Anti-tnfr2 antibody and use thereof
AssigneesJiangsu Simcere Pharmaceutical Co., Ltd., Simcere Bio-Pharmaceutical Technology., Ltd.
InventorsXinyan ZHAO, Xiaofeng ZHAO, Shiqiang LU, Ran PANG, Xinxin LI, Jinsheng REN
Life of this patent
Estimating the term…
Abstract
An antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors.
Claims21
An antibody or antigen binding fragment thereof which specifically binds to TNFR2, and which is capable of regulating function of immune cells and be used as a drug to treat diseases related to immune abnormalities, such as tumors.
13-14. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.